Citadel Advisors’s ThermoGenesis Holdings, Inc. Common Stock THMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,195
| Closed | -$11.5K | – | 15768 |
|
|
2024
Q1 | $11.5K | Sell |
16,195
-4,833
| -23% | -$3.3K | ﹤0.01% | 13407 |
|
|
2023
Q4 | $12.6K | Buy |
+21,028
| New | +$20.2K | ﹤0.01% | 12980 |
|
|
2023
Q3 | – | Sell |
-13,421
| Closed | -$16.8K | – | 15368 |
|
|
2023
Q2 | $16.8K | Buy |
+13,421
| New | +$23.4K | ﹤0.01% | 12881 |
|
|
2022
Q3 | – | Sell |
-4,338
| Closed | -$54K | – | 13866 |
|
|
2022
Q2 | $54K | Buy |
+4,338
| New | +$85.5K | ﹤0.01% | 11892 |
|
|
2021
Q2 | – | Sell |
-2,016
| Closed | -$244K | – | 14626 |
|
|
2021
Q1 | $244K | Buy |
+2,016
| New | +$262K | ﹤0.01% | 11296 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$8K | – | 9314 |
|
|
2015
Q3 | $8K | Buy |
2
+1
| +100% | +$6.09K | ﹤0.01% | 8539 |
|
|
2015
Q2 | $10K | Buy |
+1
| New | +$7.85K | ﹤0.01% | 8407 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$19K | – | 8932 |
|
|
2014
Q4 | $19K | Buy |
2
+1
| +100% | +$9.91K | ﹤0.01% | 7860 |
|
|
2014
Q3 | $15K | Buy |
+1
| New | +$12K | ﹤0.01% | 7627 |
|
|
2014
Q1 | – | Sell |
-1
| Closed | -$11K | – | 8057 |
|
|
2013
Q4 | $11K | Buy |
+1
| New | +$7.94K | ﹤0.01% | 6691 |
|
Other funds holding THMO
Citadel Advisors's THMO Position: Q2 2024 in Review
Citadel Advisors sold out of ThermoGenesis Holdings, Inc. Common Stock (THMO) in Q2 2024, closing a stake of 16,195 shares — an estimated $11.5K sold.
Citadel Advisors first reported a position in THMO in Q4 2013 and held it in 10 quarters. The position peaked at $244K in Q1 2021. 2 funds tracked by Wall St. Rank hold THMO as of Q2 2024.
- Citadel Advisors reported no remaining ThermoGenesis Holdings, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Citadel Advisors sold 16,195 ThermoGenesis Holdings, Inc. Common Stock shares in Q2 2024, an estimated $11.5K.
- Citadel Advisors first reported a position in ThermoGenesis Holdings, Inc. Common Stock in Q4 2013 and held it in 10 quarters.
- Citadel Advisors's ThermoGenesis Holdings, Inc. Common Stock position peaked at $244K in Q1 2021.
- 2 funds tracked by Wall St. Rank held ThermoGenesis Holdings, Inc. Common Stock as of Q2 2024.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.